A novel bioactive peptide-peptoid hybrid of alpha-calcitonin gene-related peptide protects against pressure-overload induced heart failure.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- A novel bioactive peptide-peptoid hybrid of alpha-calcitonin gene-related peptide protects against pressure-overload induced heart failure.
- Published In:
- Frontiers in pharmacology, 16, 1692472 (2025)
- Database ID:
- RPEP-11942
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11942APA
Kumar, Ambrish; Deloach, Sarah; Williams, Lernix; DiPette, Donald J; Potts, Jay D. (2025). A novel bioactive peptide-peptoid hybrid of alpha-calcitonin gene-related peptide protects against pressure-overload induced heart failure.. Frontiers in pharmacology, 16, 1692472. https://doi.org/10.3389/fphar.2025.1692472
MLA
Kumar, Ambrish, et al. "A novel bioactive peptide-peptoid hybrid of alpha-calcitonin gene-related peptide protects against pressure-overload induced heart failure.." Frontiers in pharmacology, 2025. https://doi.org/10.3389/fphar.2025.1692472
RethinkPeptides
RethinkPeptides Research Database. "A novel bioactive peptide-peptoid hybrid of alpha-calcitonin..." RPEP-11942. Retrieved from https://rethinkpeptides.com/research/kumar-2025-a-novel-bioactive-peptidepeptoid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.